Citadel Advisors »

Conduit Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Conduit Pharmaceuticals shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Conduit Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Conduit Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conduit Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $24k 36k 0.68

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Conduit Pharmaceuticals

Citadel Advisors
Tower Research Capital
BlackRock

View all funds holding Conduit Pharmaceuticals